The role of MAPKs in adipocyte differentiation and obesity

被引:467
作者
Bost, F [1 ]
Aouadi, M [1 ]
Caron, L [1 ]
Binétruy, B [1 ]
机构
[1] Univ Nice, Fac Med, INSERM, U568, F-06107 Nice, France
关键词
MAP kinases; obesity; adipocyte differentiation; ERK; JNK; p38; MAPK;
D O I
10.1016/j.biochi.2004.10.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ERK, p38 and INK mitogen activated protein kinases (MAPKs) are intracellular signalling pathways that play a pivotal role in many essential cellular processes such as proliferation and differentiation. MAPKs are activated by a large variety of stimuli and one of their major functions is to connect cell surface receptors to transcription factors in the nucleus, which consequently triggers long-term cellular responses. This review focuses on their in vitro and in vivo roles in adipocyte differentiation and obesity. Hyperplasia of adipose tissue is a critical event for the development of obesity. Several studies have analysed the role of MAPKs in vitro in adipocyte differentiation of preadipocyte established cell lines. In the case of ERK, although the first data appeared contradictory, a consensus scenario arises: ERK would be necessary to initiate the preadipocyte into the differentiation process and, thereafter, this signal transduction pathway needs to be shut-off to proceed with adipocyte maturation. The limitation of these cellular models is that only terminal adipocyte differentiation can be analysed, eluding the early proliferative steps of adipogenesis. New insights are now emerging by investigations conducted either in vitro with the use of embryonic stem (ES) cells or in vivo with mice where these genes are invalidated. These studies not only confirm and/or precise the various functions of MAPKs in adipogenesis but, importantly, reveal unsuspected roles, for example INK in obesity or ERK in adipogenesis of ES cells, and, for a given pathway, assign specific functions to each isoform. It appears now that a fine tuning of the MAPKs regulates both normal and pathological adipogenesis. The precise understanding of the cascade of these molecular events and the way to regulate them will be certainly crucial in order to efficiently fight obesity. (c) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 41 条
  • [1] Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade
    Aubert, J
    Dessolin, S
    Belmonte, N
    Li, M
    McKenzie, FR
    Staccini, L
    Villageois, P
    Barhanin, B
    Vernallis, A
    Smith, AG
    Ailhaud, G
    Dani, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (35) : 24965 - 24972
  • [2] INHIBITION OF ADIPOGENESIS BY THE STRESS-INDUCED PROTEIN CHOP (GADD153)
    BATCHVAROVA, N
    WANG, XZ
    RON, D
    [J]. EMBO JOURNAL, 1995, 14 (19) : 4654 - 4661
  • [3] Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins β and -δ in preadipocytes
    Belmonte, N
    Phillips, BW
    Massiera, F
    Villageois, P
    Wdziekonski, B
    Saint-Marc, P
    Nichols, J
    Aubert, J
    Saeki, K
    Yuo, A
    Narumiya, S
    Ailhaud, G
    Dani, C
    [J]. MOLECULAR ENDOCRINOLOGY, 2001, 15 (11) : 2037 - 2049
  • [4] DIFFERENTIATION OF 3T3-L1 FIBROBLASTS TO ADIPOCYTES INDUCED BY TRANSFECTION OF RAS ONCOGENES
    BENITO, M
    PORRAS, A
    NEBREDA, AR
    SANTOS, E
    [J]. SCIENCE, 1991, 253 (5019) : 565 - 568
  • [5] Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage
    Bost, F
    Caron, L
    Marchetti, I
    Dani, C
    Le Marchand-Brustel, Y
    Binétruy, B
    [J]. BIOCHEMICAL JOURNAL, 2002, 361 : 621 - 627
  • [6] BOST F, 2005, IN PRESS DIABETES
  • [7] Camp HS, 1997, J BIOL CHEM, V272, P10811
  • [8] Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes - Potential role of p38 in the downregulation of GLUT4 expression
    Carlson, CJ
    Koterski, S
    Sciotti, RJ
    Poccard, GB
    Rondinone, CM
    [J]. DIABETES, 2003, 52 (03) : 634 - 641
  • [9] Chang FM, 2003, INT J ONCOL, V22, P469
  • [10] Dani C, 1997, J CELL SCI, V110, P1279